Feet Treats That Do More Harm Than Good
Summer is finally here, and that means it's time to show off those feet. But before you get carried away trying to get that pedicure, slough off those corns or run barefoot through the park at a picnic, Tracey Vlahovic, D.P.M., associate professor of podiatric medicine and orthopedics at Temple University's School of Podiatric Medicine, hopes to dispel some common myths that could actually do more harm than good to your feet.
First New Oral Anticoagulant In More Than 40 Years Approved In Canada
Boehringer Ingelheim Canada Ltd. today announced that Health Canada has granted marketing authorization of PRADAX™ (dabigatran etexilate), a novel oral direct thrombin inhibitor (DTI) for the prevention of venous thromboembolism (VTE) in adult patients who have undergone elective total hip or total knee replacement surgery.
Depuy Spine Launches Confidence trade; System For Vertebral Compression Fractures At Spineweek
DePuy Spine, Inc., a Johnson & Johnson company, announced the worldwide launch of the CONFIDENCE SPINAL CEMENT SYSTEM™ , a novel treatment for vertebral compression fractures, a painful condition that occurs when one or more vertebrae collapse, usually as a result of osteoporosis.
Custom-Fit OtisKnee TM May Impact Early Success Of Total Knee Replacement Surgery, Study Finds
A new study from the University of Alabama at Birmingham indicates that the OtisKnee Custom Fit Knee™ Replacement system may have a positive impact on length of hospital stay, range of motion, pain level and patient satisfaction immediately following total knee replacement surgery.
Potential Therapy Discovered For Hypophosphatasia, A Congenital Form Of Rickets
Researchers at the Burnham Institute for Medical Research, led by Jose Luis Millan, Ph.D., have demonstrated in mice the first successful use of enzyme replacement therapy to prevent hypophosphatasia (HPP), a primary skeletal disease of genetic origin.
Rivaroxaban Shows Consistent Results Across Phase III Clinical Trial RECORD Programme
Phase III clinical trial results demonstrate that rivaroxaban (Xarelto ), a one tablet/once-daily, oral investigational anticoagulant, showed superior efficacy in preventing venous blood clots in patients following total knee replacement (TKR), whilst maintaining low major bleeding rates.
Play Like Tiger Woods -- On A Pain-free Knee
There may be a world of difference between Tiger Woods and your average baby boomer, but when Woods, the world's No. 1 golfer, takes to Torrey Pines in this week's U.S. Open, tens of millions of people around the country will be able to relate to one aspect of the golfer's game: his bad knee.
Denosumab Achieved Superior Bone Mineral Density Gains In Head-To-Head Trial Versus Weekly Alendronate Fosamax
Amgen (NASDAQ: AMGN) announced complete results from a head-to-head, double-blind study comparing the effects of twice-yearly subcutaneous injections of denosumab versus weekly oral doses of alendronate (FOSAMAX) on bone mineral density (BMD) in postmenopausal women with low BMD.
NICE Denies Infliximab For The Treatment Of Ankylosing Spondylitis, UK
Schering-Plough is extremely disappointed with the outcome of the National Institute for Health and Clinical Excellence (NICE) appeal panel with regards to the Final Guidance (FAD) around infliximab for the treatment of ankylosing spondylitis (AS).Schering-Plough believes that the economic modelling supporting the Institute's recommendations was highly unsatisfactory.
Sedentary High School Girls Are At Significant Risk For Future Osteoporosis
Significant numbers of female high school athletes and non athletes suffer from one or more components of the female athlete triad, a combination of three conditions that can lead to cardiovascular disease, according to a new study by Medical College of Wisconsin researchers in Milwaukee.